Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
19.87
+0.21 (1.09%)
At close: May 16, 2025, 4:00 PM
19.88
+0.02 (0.08%)
After-hours: May 16, 2025, 4:05 PM EDT
Genmab Market Cap
Genmab has a market cap or net worth of $12.23 billion as of May 16, 2025. Its market cap has decreased by -33.14% in one year.
Market Cap
12.23B
Enterprise Value
11.77B
1-Year Change
-33.14%
Ranking
Category
Stock Price
$19.87
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $12.23B, an increase of 2,809.05%. That is a compound annual growth rate of 29.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2025 | 13.01B | -5.82% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 642.38B |
| Johnson & Johnson | 352.15B |
| AbbVie | 313.43B |
| Novo Nordisk | 288.64B |
| UnitedHealth Group | 279.41B |
| Abbott Laboratories | 223.67B |
| Novartis AG | 208.47B |
| AstraZeneca | 206.71B |